Hackernews posts about Ozempic
Ozempic is a medication developed by Novo Nordisk that helps regulate blood sugar levels and treat type 2 diabetes, as well as exhibiting benefits for kidney disease patients.
Related:
Walmart Novo Nordisk
- Restaurants are changing their menus for the age of Ozempic (www.economist.com)
- Ozempic Turned a 1970s Hit into an Inescapable Jingle (2024) (www.nytimes.com)
- How long til we're all on Ozempic? (asteriskmag.com)
- Ozempic shows anti-aging effects in trial (trial.medpath.com)
- Natural occurring molecule rivals Ozempic in weight loss, sidesteps side effects (medicalxpress.com)
- Ozempic will disrupt big tobacco, candy companies, and alcohol brands (curingaddiction.substack.com)
- Ozempic does not slow Alzheimer's, study finds (www.semafor.com)
- Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes (www.nbcnews.com)
- Ozempic keeps wowing: trial data show benefits for kidney disease (www.nature.com)
- Japan: The land that doesn't need Ozempic (time.com)
- Ozempic for Sleep (isaak.net)
- First randomized trial of Ozempic for alcoholism shows big drops in drinking (recursiveadaptation.com)
- What If Ozempic Is Just a Good Thing? (nymag.com)
- Wegovy and Ozempic (semaglutide) associated with reduction in alcohol addiction (recursiveadaptation.com)
- Ozempic is changing people's skin, say plastic surgeons (www.allure.com)
- Ozempic Is Making People Buy Less Food, Walmart Says (www.bloomberg.com)
- Ozempic is causing trouble on Savile Row (www.thetimes.com)
- Why Does Ozempic Cure All Diseases? (www.astralcodexten.com)
- The Physicians Are Healing Themselves, with Ozempic (www.nytimes.com)
- The Ozempic Plateau (www.theatlantic.com)
- It's not just obesity. Drugs like Ozempic will change the world (www.economist.com)
- Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar (www.nytimes.com)
- Ozempic could delay ageing, researchers suggest (www.bbc.com)
- Life After Ozempic (english.elpais.com)
- Ozempic economics: How GLP-1s will disrupt the economy in 2025 (www.washingtonpost.com)